期刊文献+

苦参碱抑制人卵巢恶性畸胎瘤细胞株PA-1体外增殖的研究 被引量:5

Inhibitory Effect of Matrine on Proliferation of Human Ovary Malignant Teratoma Cell Line PA-1 in Vitro
下载PDF
导出
摘要 目的探讨苦参碱(matrine,MAT)对人卵巢恶性畸胎瘤细胞株PA-1体外增殖的影响。方法体外培养人卵巢恶性畸胎瘤细胞株PA-1,分组予不同浓度苦参碱作用。MTT法检测0.25、0.50、1.0 mg/mL不同浓度苦参碱对细胞增殖的抑制作用以及药物作用的量效和时效关系;流式细胞仪检测细胞凋亡和细胞周期;半定量RT-PCR检测bcl-2/bax mRNA表达水平的变化。结果MTT法显示药物作用后,细胞有明显的抑制增殖作用,且呈时间依赖性和剂量依赖性;流式细胞仪检测不同浓度的苦参碱作用后PA-1细胞的凋亡率依次上升,并与作用时间正相关;细胞周期结果显示苦参碱对PA-1细胞具有明显的G_1期阻滞作用,且具有剂量依赖性。结论苦参碱能使PA-1细胞bcl-2 mRNA和bax mRNA的比值下调,产生G_1期阻滞,从而调节细胞周期,最终导致PA-1细胞在体外的增殖受到明显抑制。 Objective To study the effect of matrine (MAT) on the proliferation of human ovary malignant teratoma cell line PA-1 in vitro. Methods PA-1 cells allocated in different groups were treated with different concentrations (0.25 mg/mL, 0. 5 mg/mL and 1.0 mg/mL) of MAT. The inhibitory effect of MAT and its doseand time-effect relationship were detected with MTT; the apoptosis rate and cell cycle were evaluated by flow cytometry; and the changes of bcl-2/bax mRNA expression in cells were measured using semi-quantitative RTPCR. Results After being exposed to MAT, the PA-1 cell proliferation was decreased in a concentration- and time-dependent manner; cell apoptosis rate raised as the increasing concentration of MAT and acting time; cells retarded at G1 phase in the cell cycle dose-dependently; and the bcl-2/bax mRNA expression in cells dawn-regulated significantly. Conclusion MAT can dose- and time-dependently inhibit the proliferation of PA-1 cell by reducing bcl-2/bax mRNA ratio to produce a G1 phase arresting in cell cycle.
出处 《中国中西医结合杂志》 CAS CSCD 北大核心 2010年第7期723-725,共3页 Chinese Journal of Integrated Traditional and Western Medicine
基金 浙江省自然基金资助项目(No.Y204463) 浙江省卫生厅重点项目(No.2004ZD009)
关键词 苦参碱 PA-1细胞 细胞周期 增殖 matrine PA-1 cell cell cycle proliferation
  • 相关文献

参考文献7

二级参考文献18

  • 1毛慧生,刘洪■,李川,宋燕爽,孙慧,冯玉梅,苏明秀.苦参碱对肿瘤细胞恶性表型及免疫功能的调控作用[J].中国肿瘤临床,1996,23(11):799-803. 被引量:59
  • 2Zhang LP,Jiang JK,Tam JW,et al.Effects of matrine on proliferation and differentiation in K-562 cells.Leuk Res,2001,25:793-800. 被引量:1
  • 3Hahn WC.Targeting cancer with telomerase.Clin Cancer Res,2004,10:1203-1205. 被引量:1
  • 4Hammond PW,Cech TR,Hammond PW,et al.Euplotes telomerase:evidence for limited base-pairing during primer elongation and dGTP as an effector of translocation.Biochemistry,1998,37:5162-5172. 被引量:1
  • 5Shay JW,Wright WE.Telomerase activity in human cancer.Curr Opin Oncol,1996,8:66-71. 被引量:1
  • 6Jiang F,Bao JY,Li PF,et al.Induction of ovarian cancer cell apoptosis by 1,25-Dihydroxyvitamin D3 through the down-regulation of telomerase.J Biol Chem,2004,279:53213-53221. 被引量:1
  • 7Akeshima R,Kigawa J,Takahashi M,et al.Telomerase activity and p53-dependent apoptosis in ovarian cancer cells.Br J Cancer,2001,84:1551-1555. 被引量:1
  • 8Mandal M,Kumar R.Bcl-2 modulates telomerase activity.J Biol Chem,1997,272:14183-14187. 被引量:1
  • 9Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science, 1994,266:2011-2015. 被引量:1
  • 10LANKAS G R,WISE L D,CARTWRIGHT M E,et al.Placental P-glycoprotein deficiency enhances susceptibility to chemically induced birth defects in mice[J].Roprod Toxicol,1998,12(4):457-463. 被引量:1

共引文献106

同被引文献96

引证文献5

二级引证文献54

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部